Childhood Cancer

You are here

Home » Grants » All grants tagged with "Solid and Bone Cancers"

All grants tagged with "Solid and Bone Cancers"

Establishment of a Cohort of Pediatric Patients at United States Children’s Hospitals with Newly Diagnosed Neuroblastoma with Administrative Data from the Pediatric Health Information System (PHIS) Database
Nicole Herbst
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2012
Are Ewing sarcoma Stem Cells (ESSCs) Resistant to Anti-IGF-IR Therapy?
Alison O'Neill
Georgetown University
POST Program Grants, Awarded 2011
The Role of the Receptor Tyrosine Kinase FGFR4 in Human Alveolar Rhabdomyosarcoma Tumorigenesis.
Julie Kephart
Duke University
POST Program Grants, Awarded 2011
Uncovering remaining genes critical to hereditary Neuroblastoma etiology to provide a comprehensive view of the roots of this enigmatic tumor and reveal additional targets for new, effective therapies.
Marci Laudenslager
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2011
Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma
Ken Lucas, MD
The Pennsylvania State University
Innovation Grants, Awarded 2006
Gene Network Analysis in Childhood Cancer
Rheanne Zimmerman
University of Minnesota
POST Program Grants, Awarded 2013
Investigation of EWS-WT1 as a Therapeutic Target for Desmoplastic Small Round Cell Tumor (DSRCT)
Heather Wilson
Vanderbilt University Medical Center
POST Program Grants, Awarded 2013
Role of Exosomic miRNAs in the Development of Drug Resistance in Neuroblastoma (NBL)
Brandon Twardy
Children’s Hospital Los Angeles
POST Program Grants, Awarded 2013
Evaluation of MIBG Transporters in Neuroblastoma
William Temple
University of California San Francisco
POST Program Grants, Awarded 2013
Creation and Validation of Novel Cell Line Models for Alveolar Rhabdomyosarcoma
Kaoru Takasaki
Yale School of Medicine
POST Program Grants, Awarded 2013

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »